Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
暂无分享,去创建一个
O. Sommerburg | M. Mall | M. Stahl | S. Hirtz | S. Graeber | S. Hämmerling | H. Scheuermann | Yin Yu | A. Krümpelmann | J. Berges